Duan X, et al
Novo Nordisk has argued that as the first amylin-based combination on the market, CagriSema will carry the strongest weight-loss label of any product available at its anticipated launch date, and that the amylin mechanism which suppresses post-meal glucagon through a pathway distinct from GLP-1 offers a differentiated clinical profile
Results Participants Between February 4, 2022, and August 8, 2023, 1214 individuals signed informed consent, of whom 546 were randomised and 544 exposed to treatment
Milk thistle is another common pairing, particularly for those interested in liver support
caution is required in patients with kidney disease, gastrointestinal disorders, or those taking insulin or sulfonylureas, as the risk of low blood sugar (hypoglycemia) may increase when combined with other glucose-lowering medications
Common side effects include: In most cases taking L-carnitine supplement orally and properly as recommended (2g or less per day) is considered safe without any side effects